| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| SUGARBUD CRAFT GROWERS Aktie jetzt für 0€ handeln |
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| NOVO NORDISK | 32,060 | +0,36 % | Milliardenmarkt vor Umbruch: Angriff auf Eli Lilly und Novo Nordisk: Roche wittert Milliardenchance | © Foto: Udo Herrmann - picture alliance / CHROMORANGERoche will im boomenden Markt für Abnehm-Medikamente wieder angreifen. Der Konzern setzt auf neue Strategien und Milliarden-Deals im Wettbewerb.Der... ► Artikel lesen | |
| MERCK KGAA | 103,35 | 0,00 % | EQS-PVR: Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution | EQS Voting Rights Announcement: Merck KGaA
Merck KGaA: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide... ► Artikel lesen | |
| AURORA CANNABIS | 2,895 | +0,52 % | K-Tech Solutions Company Limited Announces Joint Venture with Aurora AZ Energy Ltd. to Develop up to 500 MW of AI and HPC Infrastructure in Canada | HONG KONG and NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- K-Tech Solutions Company Limited (Nasdaq: KMRK) ("K-Tech" or the "Company"), a technology firm specializing in high-performance computing infrastructure... ► Artikel lesen | |
| GSK | 22,810 | 0,00 % | BARCLAYS stuft GSK auf 'Underweight' | LONDON (dpa-AFX Analyser) - Die britische Investmentbank Barclays hat die Einstufung für GSK mit einem Kursziel von 1900 Pence auf "Underweight" belassen. Jüngste Absatzdaten belegten auf Wochensicht... ► Artikel lesen | |
| CANOPY GROWTH | 0,816 | -0,49 % | Cannabis-Boom 2026: Warum Bioxyne und Canopy jetzt das Spielfeld in Deutschland besetzen | ||
| ASTRAZENECA | 160,25 | -0,09 % | AstraZeneca reportedly hit by serious cyberattack | ||
| TILRAY BRANDS | 5,720 | -1,72 % | Monday newspaper round-up: Palantir, BrewDog, Darktrace | ||
| TEVA | 25,000 | -0,40 % | Teva Pharmaceutical Industries Ltd: Teva Releases Q1 2026 Aide Memoire | TEL AVIV, Israel, March 19, 2026 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced today that its Q1 2026 Aide Memoire is available on the "Investors" page on its... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 387,85 | -0,69 % | VERTEX PHARMACEUTICALS INC in ruhiger Marktstruktur | ||
| INNOCAN PHARMA | 4,120 | -1,90 % | Was große Adressen über InnoCan Pharma wissen - und Sie noch nicht | ||
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | TAAT Global Alternatives Inc (2): TAAT Global CEO Saxon resigns | ||
| CRONOS GROUP | 2,180 | +1,87 % | Cronos Group Inc.: Cronos Group Reports 2025 Fourth Quarter and Full-Year Results | Net revenue in Q4 2025 increased by 47% year-over-year to $44.5 million; Net revenue in FY 2025 increased by 25% year-over-year to $146.6 million Achieved record net revenue in Q4 2025 and FY 2025... ► Artikel lesen | |
| DIGICANN VENTURES | 0,004 | 0,00 % | Digicann Ventures Inc.: Digicann Ventures Announces Agreement to Extend Maturity Date for Convertible Debentures | Vancouver, British Columbia--(Newsfile Corp. - March 12, 2026) - Digicann Ventures Ltd. (CSE: DCNN.X) ("Digicann" or the "Company"), a company focused on opportunities within and outside of the... ► Artikel lesen | |
| BAUSCH HEALTH | 4,227 | -1,96 % | Bausch Health Companies Posts Q4 Loss | OTTAWA (dpa-AFX) - Bausch Health Companies Inc. (BHC, BHC.TO) on Wednesday reported a net loss of $112 million for the fourth quarter, compared with a consolidated net income of $93 million... ► Artikel lesen | |
| ORGANIGRAM GLOBAL | 1,120 | -4,27 % | Organigram Global Inc: Organigram garners ISS support for Sanity transaction |